000

BIOPLUS

No trades
See on Supercharts
Market capitalization
‪370.76 B‬KRW
‪25.58 B‬KRW
‪65.04 B‬KRW
‪34.18 M‬
Beta (1Y)
0.39

About BIOPLUS

CEO
Hyun-Kyu Jung
Headquarters
Seongnam-si
Employees (FY)
116
Founded
2003
ISIN
KR7099430001
FIGI
BBG0125CXPH2
BioPlus Co., Ltd. is engaged in the manufacturing and supplying of diverse dermal fillers. Its product includes SkinPlus - Hyal Implant, Bio+ Dew, HyalDew All, HyalDew Mid, HyalDew Fine, HyalDew Shine, DeneB Classic-H,S, Stilea and 3-Senses. The company was founded on May 23, 2003 and is headquartered in Seongnam-si, South Korea.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of 099430 is 6450 KRW — it has increased by 0.78% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange BIOPLUS stocks are traded under the ticker 099430.
099430 stock is 3.13% volatile and has beta coefficient of 0.39. Check out the list of the most volatile stocks — is BIOPLUS there?
BIOPLUS revenue for the last quarter amounts to ‪14.10 B‬ KRW despite the estimated figure of ‪13.95 B‬ KRW. In the next quarter revenue is expected to reach ‪15.20 B‬ KRW.
Yes, you can track BIOPLUS financials in yearly and quarterly reports right on TradingView.
099430 stock has risen by 0.94% compared to the previous week, the month change is a 7.46% fall, over the last year BIOPLUS has showed a 1.07% decrease.
099430 net income for the last quarter is ‪6.70 B‬ KRW, while the quarter before that showed ‪5.49 B‬ KRW of net income which accounts for 21.92% change. Track more BIOPLUS financial stats to get the full picture.
Yes, 099430 dividends are paid annually. The last dividend per share was 70.00 KRW. As of today, Dividend Yield (TTM)% is 1.09%. Tracking BIOPLUS dividends might help you take more informed decisions.
BIOPLUS dividend yield was 1.02% in 2023, and payout ratio reached 15.74%. The year before the numbers were 1.01% and 18.83% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, 099430 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade BIOPLUS stock right from TradingView charts — choose your broker and connect to your account.
099430 reached its all-time high on Sep 27, 2021 with the price of 10750 KRW, and its all-time low was 5090 KRW and was reached on Dec 1, 2021.
See other stocks reaching their highest and lowest prices.
As of Apr 29, 2024, the company has 116.00 employees. See our rating of the largest employees — is BIOPLUS on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So BIOPLUS technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating BIOPLUS stock shows the strong sell signal. See more of BIOPLUS technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. BIOPLUS EBITDA is ‪30.49 B‬ KRW, and current EBITDA margin is 46.83%. See more stats in BIOPLUS financial statements.